Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Children's Oncology Group
Active, not recruiting ID
For more information, see NCT01503632
This randomized phase III trial studies compliance to a mercaptopurine treatment intervention
compared to standard of care in younger patients with acute lymphoblastic leukemia that has
had a decrease in or disappearance of signs and symptoms of cancer (remission). Assessing
ways to help patients who have acute lymphoblastic leukemia to take their medications as
prescribed may help them in taking their medications more consistently and may improve
treatment outcomes.
Behavioral Intervention, Compliance Monitoring, Laboratory Biomarker Analysis, Mercaptopurine, Questionnaire Administration, Standard Follow-Up Care
Childhood Acute Lymphoblastic Leukemia in Remission
Smita Bhatia

See list of participating sites